Virtu Financial’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Virtu Financial’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,073	Closed	-$4.14M	–	2345
2023 Q4	$4.14M	Buy	+13,073	New	+$2.54M	0.33%	38
2023 Q3	–	Sell	-2,320	Closed	-$503K	–	2105
2023 Q2	$503K	Sell	2,320 -3,550	-60%	-$761K	0.04%	399
2023 Q1	$1.07M	Buy	5,870 +4,765	+431%	+$911K	0.11%	177
2022 Q4	$217K	Sell	1,105 -3,143	-74%	-$674K	0.03%	664
2022 Q3	$955K	Buy	+4,248	New	+$860K	0.09%	208
2021 Q3	–	Sell	-4,081	Closed	-$465K	–	2112
2021 Q2	$465K	Buy	+4,081	New	+$477K	0.05%	508
2020 Q3	–	Sell	-4,775	Closed	-$532K	–	1643
2020 Q2	$532K	Buy	+4,775	New	+$415K	0.06%	356
2019 Q4	$353K	Buy	+4,686	New	+$205K	0.03%	590

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Virtu Financial's KRTX Position: Q1 2024 in Review

Virtu Financial sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 13,073 shares — an estimated $4.14M sold.

Virtu Financial first reported a position in KRTX in Q4 2019 and held it in 8 quarters. The position peaked at $4.14M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Virtu Financial reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Virtu Financial sold 13,073 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $4.14M.
Virtu Financial first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2019 and held it in 8 quarters.
Virtu Financial's Karuna Therapeutics, Inc. Common Stock position peaked at $4.14M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.